Cargando…
An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840117/ https://www.ncbi.nlm.nih.gov/pubmed/29520389 http://dx.doi.org/10.4111/icu.2018.59.2.126 |
_version_ | 1783304509497278464 |
---|---|
author | Sandberg, Jason M. Gray, Ian Pearlman, Amy Terlecki, Ryan P. |
author_facet | Sandberg, Jason M. Gray, Ian Pearlman, Amy Terlecki, Ryan P. |
author_sort | Sandberg, Jason M. |
collection | PubMed |
description | PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that inspired the United States (US) Food and Drug Administration's 2008 Public Health Notification. Entries were compiled into a categorical database that reported manufacturer, brand, reporter type, report source, and type of adverse event. RESULTS: There were numerous examples of missing, duplicated, and non-standardized entries. Analysis revealed 64 reports with duplicated information, and six reports representing multiple patients. Forty-seven percent of medical device reports did not identify a reporter source. At least 28% of reported devices are no longer on the US market. There was wide variability in the quality and completeness of submitted reports and true adverse event rates could not be accurately calculated because the number of total cases was unknown. CONCLUSIONS: The MAUDE database was limited in its ability to collect, quantify, and standardize real-life adverse events related to transvaginal mesh. While it functions to collect information related to isolated adverse events, systematic limitations of the MAUDE database, that no doubt extend to other medical devices, necessitate the development of new reporting systems. Alternatives are under development, which may allow regulators to more accurately scrutinize the safety profiles of specific medical devices. |
format | Online Article Text |
id | pubmed-5840117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-58401172018-03-08 An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh Sandberg, Jason M. Gray, Ian Pearlman, Amy Terlecki, Ryan P. Investig Clin Urol Original Article PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that inspired the United States (US) Food and Drug Administration's 2008 Public Health Notification. Entries were compiled into a categorical database that reported manufacturer, brand, reporter type, report source, and type of adverse event. RESULTS: There were numerous examples of missing, duplicated, and non-standardized entries. Analysis revealed 64 reports with duplicated information, and six reports representing multiple patients. Forty-seven percent of medical device reports did not identify a reporter source. At least 28% of reported devices are no longer on the US market. There was wide variability in the quality and completeness of submitted reports and true adverse event rates could not be accurately calculated because the number of total cases was unknown. CONCLUSIONS: The MAUDE database was limited in its ability to collect, quantify, and standardize real-life adverse events related to transvaginal mesh. While it functions to collect information related to isolated adverse events, systematic limitations of the MAUDE database, that no doubt extend to other medical devices, necessitate the development of new reporting systems. Alternatives are under development, which may allow regulators to more accurately scrutinize the safety profiles of specific medical devices. The Korean Urological Association 2018-03 2018-01-29 /pmc/articles/PMC5840117/ /pubmed/29520389 http://dx.doi.org/10.4111/icu.2018.59.2.126 Text en © The Korean Urological Association, 2018 http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sandberg, Jason M. Gray, Ian Pearlman, Amy Terlecki, Ryan P. An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title | An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title_full | An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title_fullStr | An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title_full_unstemmed | An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title_short | An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh |
title_sort | evaluation of the manufacturer and user facility device experience database that inspired the united states food and drug administration's reclassification of transvaginal mesh |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840117/ https://www.ncbi.nlm.nih.gov/pubmed/29520389 http://dx.doi.org/10.4111/icu.2018.59.2.126 |
work_keys_str_mv | AT sandbergjasonm anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT grayian anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT pearlmanamy anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT terleckiryanp anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT sandbergjasonm evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT grayian evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT pearlmanamy evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh AT terleckiryanp evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh |